Trinity Biotech | TRIB - Selling And Administration Expenses


Trinity Biotech reported $6.19M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Bayer EUR 3.7B 356M Mar/2026
Bio-Rad Laboratories USD 221M 14.2M Dec/2025
EDAP TMS EUR 8.81M 1.57M Sep/2025
J&J USD 6.03B 719M Mar/2026
Mesa Laboratories USD 27.31M 380K Sep/2024
OraSure Technologies USD 13.21M 3.29M Dec/2025
Plus Therapeutics USD 3.49M 559K Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Siemens EUR 3.56B 45M Mar/2026
Surmodics USD 11.4M 3.18M Jun/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Tosoh JPY 44.48B 2.96B Mar/2026
Trinity Biotech USD 6.19M 2.18M Sep/2025
Veracyte USD 50.84M 7.53M Mar/2026